This inventor holds 6 USPTO granted patents and 2 published patent applications and 5 EPO patents. Top assignees: Ingenium Pharmaceuticals Gmbh, Astrazeneca Ab. Active years: 2013-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Loerrach-Haagen, DE (2013 - 2014)
- Lörrach-Haagen, DE (2014)
Company Filing History:
Years Active: 2013-2014
Title: The Innovations of Hans Allgeier
Introduction
Hans Allgeier is a notable inventor based in Loerrach-Haagen, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for protein kinases. With a total of six patents to his name, Allgeier's work has implications for various therapeutic applications.
Latest Patents
One of Hans Allgeier's latest patents focuses on inhibitors of cyclin-dependent kinases. This invention relates to methods for preventing and treating various conditions, including pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases, and neurodegenerative diseases. The administration of an effective amount of at least one inhibitor of cyclin-dependent kinases is central to this therapeutic approach. Another patent involves compounds of general formula (I), which are useful as inhibitors of cyclin-dependent kinases such as CDK9.
Career Highlights
Throughout his career, Hans Allgeier has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Ingenium Pharmaceuticals GmbH and AstraZeneca AB. His work in these organizations has allowed him to advance his research and contribute to the development of innovative treatments.
Collaborations
Hans Allgeier has collaborated with several professionals in his field, including Martin Augustin and Michael A Pleiss. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Hans Allgeier's contributions to the field of biochemistry through his innovative patents highlight his role as a significant inventor. His work on inhibitors of protein kinases has the potential to transform therapeutic approaches for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile